Table 2 miRNA and diabetic retinopathy
From: Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets
Refs | Study type | Identified miRNA |
|---|---|---|
Graefes Arch Clin Exp Ophthalmol [40] | Clinical study (serum & vitreous) | miR-15a, miR-320b, miR-93, miR-423-5p, miR-29a, miR-320a |
Diabetes [23] | Clinical study (serum) | miR-27b, miR-454, miR-28-3p, miR-122, miR-320a, miR-125b, miR-221 |
Sci Rep [60] | Clinical study (serum) | miR-125b, miR-221, miR-132, miR-100, miR-376a |
IOVS Nuria [41] | Clinical study (E/PCs) | miR-221, miR-126, miR-222 |
Cell Physiol Biochem [42] | Clinical study (serum) | miR-21, miR-181c, miR-1179 |
FEBS Lett [43] | Invitro/animal OIR mice study Retina | miR-184 |
BRBC [44] | Invitro/animal study Retina | miR-192-5P, miR-335 |
Diabetologia [34] | Invitro/animal diabetic rats (E/PCs) | miR-195 |
Circ Res [45] | Invitro/animal (STZ diabetic rat/db/db mice) Retina/(E/PCs) | IncRNA-myocardial infarction-associated transcript (MIAT)and miR—150 |
Int J Med Sci [46] | Invitro/animal STZ diabetic rat study Retina | miR-126 |
Mol Vis [47] | Invitro/animal STZ diabetic rat study Retina | miR-29b |
IOVS [48] | Invitro/animal Akita mouse/(E/PCs) | miR-146,miR-200b |
IOVS [49] | Invitro/animal Retina/(E/PCs) | miR-200b |
IOVS [50] | Invitro/animal Akita and wild-type (WT) mice study Retina | miR-200b |
Diabetes [51] | Invitro/animal (STZ diabetic rat) study Retina | miR-200b |
Molecular Therapy [52] | Animal study (mice with oxygen-induced ischemic retinopathy) retina | miR-106a,-146,-181,-199a,-214,-424, -451 miR-31, miR-150, miR-184 |
The International Journal of Biochemistry & Cell Biology [32] | Invitro study In vitro cell proliferation analyses | MiR-18b |